Ian Sheffield bought $26k of GUTS
director at Fractyl Health, Inc.. 35,000 shares at an average of $0.73, traded Jun 10, 2026, filed Jun 11, 2026.
Score components
- +15RoleDirector
- +5Trade size$26k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context69% below the 52-week high
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-267838, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | POpen-market purchase Common Stock | +35,000 | $0.73 | $26k | 35,000 | Jun 11, 2026 |
| Jun 10, 2026 | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 11, 2026 |
Related signals
Other insiders at Fractyl Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | GUTSbuy Fractyl Health, Inc. | William Bradley director | $40k 64,516 shares | +76% | |
| 48Moderate | Fractyl Health, Inc. | Ajay Royan director | $20k 23,000 shares | +128% | |
| 55Moderate | Fractyl Health, Inc. | William Bradley director | $50k 68,493 shares | +425% | |
| 48Moderate | Fractyl Health, Inc. | Harith Rajagopalan Chief Executive Officer | $18k 25,000 shares | +5% | |
| 53Moderate | Fractyl Health, Inc. | Weber Lara Smith Chief Financial Officer | $14k 20,000 shares | - | |
| 33Weak | GUTSbuy Fractyl Health, Inc. | Harith Rajagopalan Chief Executive Officer | $20k 10,416 shares | +2% | |
| 44Moderate | Fractyl Health, Inc. | Kelly Ann Barnes director | $40k 31,000 shares | - | |
| 38Weak | Fractyl Health, Inc. | Ajay Royan director, owner | $23k 17,901 shares | - | |
| 38Weak | Fractyl Health, Inc. | William Bradley director | $20k 16,129 shares | - | |
| 38Weak | Fractyl Health, Inc. | Samuel Conaway director | $9,964 8,550 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.